Dermata Therapeutics, Inc.
DRMA
$5.50
-$0.33-5.66%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 31.00% | 105.32% | -57.49% | -7.35% | -41.37% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 4.41% | -19.68% | -19.94% | -14.62% | -29.79% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -94.46% | -97.85% | -86.18% | -76.38% | 116.34% |
Total Current Assets | 26.81% | 93.15% | -55.71% | -8.69% | -39.90% |
|
|||||
Total Current Assets | 26.81% | 93.15% | -55.71% | -8.69% | -39.90% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 26.81% | 93.15% | -55.71% | -8.69% | -39.90% |
|
|||||
Total Accounts Payable | -68.83% | 69.64% | -6.70% | 82.00% | 203.15% |
Total Accrued Expenses | 3.62% | 138.26% | 53.75% | 144.69% | 141.21% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -46.50% | 97.10% | 21.51% | 112.27% | 180.92% |
|
|||||
Total Current Liabilities | -46.50% | 97.10% | 21.51% | 112.27% | 180.92% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -46.50% | 97.10% | 21.51% | 112.27% | 180.92% |
|
|||||
Common Stock & APIC | 20.15% | 24.78% | 12.54% | 16.66% | 8.87% |
Retained Earnings | -17.40% | -20.27% | -23.02% | -21.99% | -19.82% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 69.20% | 91.73% | -75.44% | -26.00% | -58.68% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 69.20% | 91.73% | -75.44% | -26.00% | -58.68% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 69.20% | 91.73% | -75.44% | -26.00% | -58.68% |
|